It could be speculated that the MetS-related NAFLD and the PNPLA3-related NAFLD may differently impact on cardio-metabolic risk and that NAFLD is more associated to atherosclerosis when it is linked to MetS traits independently of PNPLA3 genotype [63]. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.